Back to Stock Dashboard
Sector:
Financial Services
Add to portfolio
BME
BlackRock Health Sciences Trust
BlackRock Health Sciences Trust (BME) is rated C+ (2.7/5) on Deltasharpe Prism, scored against Financial Services sector peers. Its strongest pillar is Growth (B+); its weakest is Revisions (C-).
Quantitative Factor Evaluation • Updated
Overall Rating
2.7
/ 5.0
C+
Value
C+
Factor Score
2.6
/ 5.0
Growth
B+
Factor Score
3.7
/ 5.0
Profitability
C+
Factor Score
2.8
/ 5.0
Momentum
C+
Factor Score
2.5
/ 5.0
Revisions
C-
Factor Score
1.9
/ 5.0
Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms
Ratings of B- and above are for members.
Register free to see every rating — your first 2 weeks of Premium are on us.
Register — 2 weeks freeUnderlying Financial Metrics
P/E Ratio
7.3
EV / EBITDA
0.0
Rev Growth YoY
7.6%
Gross Margin
N/M
Price Return 3M
12.5%
Price Return 12M
31.5%
Catalyst Signal
0.00
Market Cap
N/A
TTM Revenue
N/A
Price / Sales
7.3
ROE
13.8%
Historical Factor Score Progression
| Date | Value | Growth | Profitability | Momentum | Revisions | Overall |
|---|---|---|---|---|---|---|
| 2026-08-05 | C+ (2.6) | B+ (3.7) | C+ (2.8) | C+ (2.5) | C- (1.9) | C+ (2.7) |
| 2026-08-04 | C+ (2.6) | B+ (3.7) | C+ (2.8) | B (3.2) | C- (2.0) | B- (2.9) |
| 2026-08-03 | C+ (2.6) | C+ (2.8) | C+ (2.7) | B (3.2) | C- (2.0) | C+ (2.7) |
| 2026-08-02 | C+ (2.6) | C+ (2.8) | C+ (2.7) | B (3.2) | C- (1.9) | C+ (2.6) |